Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,216 | 0,240 | 12.09. | |
0,218 | 0,236 | 12.09. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
BRII BIOSCIENCES Aktie jetzt für 0€ handeln | |||||
27.08. | BRII-B (02137): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2024 | 3 | HKEx | ||
25.08. | Leerink Partners raises Brii Biosciences stock price target to HK$2.00 on HBV data | 2 | Investing.com | ||
25.08. | BRII-B (02137): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
21.08. | Brii Biosciences reports 1H results | 1 | Seeking Alpha | ||
21.08. | Brii Biosciences Limited: Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results | 61 | PR Newswire | Multiple Ongoing Phase 2b Studies Advancing HBV Functional Cure Strategy
Greater China Partnership with Joincare to Accelerate Development of Critical Care Antibiotic... ► Artikel lesen | |
21.08. | BRII-B (02137): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 | 1 | HKEx | ||
11.08. | BRII-B (02137): DATE OF BOARD MEETING | 1 | HKEx | ||
04.07. | Brii Biosciences and Joincare sign licence agreement for BRII-693 | 1 | Pharmaceutical Technology | ||
04.07. | BRII-B (02137): VOLUNTARY ANNOUNCEMENT LICENSE AGREEMENT WITH JOINCARE | 2 | HKEx | ||
03.06. | BRII-B (02137): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
03.06. | BRII-B (02137): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 3, 2025 AND CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE | 1 | HKEx | ||
08.05. | BRII-B (02137): VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE | 1 | HKEx | ||
28.04. | BRII-B (02137): CLARIFICATION ANNOUNCEMENT (1) CHANGE OF DATE OF ANNUAL GENERAL MEETING; AND (2) CHANGE OF CLOSURE OF THE REGISTER OF MEMBERS | 1 | HKEx | ||
25.04. | BRII-B (02137): NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS | 1 | HKEx | ||
25.04. | BRII-B (02137): NOTIFICATION LETTER AND CHANGE REQUEST FORM FOR REGISTERED SHAREHOLDERS | - | HKEx | ||
25.04. | BRII-B (02137): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | - | HKEx | ||
25.04. | BRII-B (02137): FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING | - | HKEx | ||
25.04. | BRII-B (02137): NOTICE OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
25.04. | BRII-B (02137): (1) PROPOSALS FOR ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS; (2) RE-ELECTION OF RETIRING DIRECTORS; (3) RE-APPOINTMENT ... | - | HKEx | ||
25.04. | BRII-B (02137): 2024 ANNUAL REPORT | - | HKEx |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BIOGEN | 124,00 | +0,40 % | Große Kursgewinne für die Biogen-Aktie (125,6827 €) | Die Aktie von Biogen zählt heute zu den großen Gewinnern an der Börse. Der Titel steigt deutlich. Grund zur Freude haben Aktionäre von Biogen: Das Papier weist derzeit einen Wertanstieg von 3,43 Prozent... ► Artikel lesen | |
ILLUMINA | 82,42 | +1,67 % | Chinese Market Share of Domestic Gene Sequencers Rise in First Half Amid Illumina Import Ban | ||
NANOREPRO | 1,815 | +4,01 % | HV-Termine: Hauptversammlungen u.a. bei Baywa, Circus, Daldrup, Laiqon, NanoRepro, Pyramid, Umweltbank | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
BRAIN BIOTECH | 2,190 | -1,79 % | EQS-News: BRAIN Biotech AG: BRAIN Biotech ernennt Johan Jansén-Storbacka zum Executive Vice President BRAINBiocatalysts für den Bereich Enzymprodukte | EQS-News: BRAIN Biotech AG
/ Schlagwort(e): Personalie
BRAIN Biotech ernennt Johan Jansén-Storbacka zum Executive Vice President BRAINBiocatalysts für den Bereich Enzymprodukte... ► Artikel lesen | |
BIONXT SOLUTIONS | 0,530 | +1,14 % | Übernahmekandidat! Novo Nordisk und Eli Lilly bei BioNxt Solutions auf der Lauer | Eine Depotrakete für die kommenden Wochen? Da ist die Aktie von BioNxt Solutions mindestens einen Blick wert. Denn von Sommerloch konnte bei dem Unternehmen keine Rede sein. Stattdessen ging es Schlag... ► Artikel lesen | |
INFLARX | 1,081 | +1,50 % | InflaRx N.V.: InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement | JENA, Germany, Sept. 12, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system (the "Company")... ► Artikel lesen | |
SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem Corp.: Sirona Biochem Update to Shareholders on Financial Status and Operations | VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) ("Sirona") wishes to provide shareholders with a critical update on the company's financial... ► Artikel lesen | |
DEFENCE THERAPEUTICS | 0,421 | -3,00 % | Defence Therapeutics Inc.: Defence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth | Montreal, Quebec--(Newsfile Corp. - September 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specialized in... ► Artikel lesen | |
TREVENA | 2,280 | -40,00 % | Hollywood Changemaker Oliver Trevena Joins Little Kitchen Academy as Investor | LOS ANGELES, CA / ACCESS Newswire / August 21, 2025 / Little Kitchen Academy (LKA), the premier Montessori-inspired cooking academy for children and teens ages 3-18, is proud to announce that Oliver... ► Artikel lesen | |
BURCON NUTRASCIENCE | 1,380 | -4,83 % | Burcon NutraScience Corporation: Burcon Achieves First Commercial Sales of High-Purity Canola Protein | Vancouver, British Columbia--(Newsfile Corp. - September 10, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based... ► Artikel lesen | |
TME PHARMA | 0,098 | +2,63 % | TME Pharma N.V.: TME Pharma Completes August Financing and Publishes Cash Position | TME Pharma has completed the fund raise announced last August 25th, receiving €500k in cash on August 28th in addition to the €1.7M raised end of May Cash position €2.35M at end of August... ► Artikel lesen | |
CYTODYN | 0,234 | 0,00 % | CytoDyn Inc.: CytoDyn Announces Encouraging Survival Data in Patients with Metastatic Colorectal Cancer Previously Treated with Leronlimab | Positive results in patients with advanced mCRC emphasize potential significance of CytoDyn's ongoing Phase II CRC trial Dr. Benjamin Weinberg to present final results at the ESMO Gastrointestinal... ► Artikel lesen | |
IMMUNIC | 0,670 | -1,18 % | EQS-News: Immunic AG: Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis | Issuer: Immunic AG
/ Key word(s): Patent
Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple... ► Artikel lesen | |
PHIO PHARMACEUTICALS | 2,190 | -5,60 % | Phio Pharmaceuticals Corp. - S-8, Securities to be offered to employees in employee benefit plans | ||
IOVANCE BIOTHERAPEUTICS | 1,961 | +1,17 % | Iovance Biotherapeutics stellt auf H.C. Wainwright Konferenz Strategie für Wachstum und Effizienz vor |